{"id":"W618788809","doi":"","title":"What's going on 放射線 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. N Engl J Med. 2005; 352: 987-96. PMID: 15758009.--神経膠腫に対する治療として、放射線治療とテモゾロマイドの併用が世界的な標準的治療となりうることを示唆する論文","year":2006,"lang":"ja","type":"article","venue":"Mebio oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":772,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Temozolomide; Glioblastoma; Radiation therapy; Concomitant; Medicine; Nuclear medicine; Internal medicine; Cancer research","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001916389,0.0003990649,0.001722092,0.0004266028,0.0005171919,0.001346185,0.0007452765,0.002281346,0.006589013],"category_scores_gemma":[0.003531153,0.000249915,0.002050394,0.0005042797,0.0008459178,0.002100536,0.0003589631,0.001939038,0.001018662],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001306988,"about_ca_system_score_gemma":0.002682785,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004002272,"about_ca_topic_score_gemma":0.01907229,"domain_scores_codex":[0.9991812,0.000349279,0.0001363918,0.00004936296,0.0001652264,0.000118521],"domain_scores_gemma":[0.998489,0.0005398549,0.0003159313,0.00006691024,0.0001818714,0.000406384],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.08210728,0.004409643,0.004549395,0.01957809,0.003034611,0.0003804489,0.0003585914,0.0006452937,0.004238909,0.002079933,0.04202281,0.8365951],"study_design_scores_gemma":[0.1125993,0.1222049,0.06588315,0.05427137,0.01537455,0.002287812,0.003261408,0.002337486,0.008758148,0.009859421,0.6027355,0.0004269209],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"commentary","genre_scores_codex":[0.1466691,0.7300131,0.0005155893,0.08741847,0.02167838,0.001003333,0.0007333298,0.00007855998,0.0118902],"genre_scores_gemma":[0.5143675,0.3627263,0.003471283,0.08569861,0.02196024,0.0009208285,0.0009056986,0.00005459994,0.009894925],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.006589013,"threshold_uncertainty_score":0.02204251,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09719568561048682,"score_gpt":0.4371076186917973,"score_spread":0.3399119330813105,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}